Research & Development
FDA accepts Genentech's giredestrant application for early-stage breast cancer
2 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Appli...
Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC
2 June 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Monday that it has received marketing authorisation from the European Commission for IMDYLLTRA (tarlatamab) as a monotherapy...
Haisco receives US FDA approval for anaesthetic Cipepofol
...
Hanmi signs licensing deal with Lilly for sonefpeglutide
1 June 2026 - South Korea-based pharmaceutical company Hanmi Pharm. Co. Ltd. announced on Monday that it has entered into a licence agreement for the development, manufacturing and commercialisation o...
FDA approves TREMFYA label expansion
29 May 2026 - Pharmaceutical company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Thursday that the US Food and Drug Administration (FDA) has approved a supplemental Biologics License Appli...
GSK reports positive phase III data for bepirovirsen in chronic hepatitis B
28 May 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) on Thursday reported positive phase III results for bepirovirsen, its investigational treatment for chronic hepatitis B, with poole...